List of insiders holdings for ChemoCentryx Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Vifor (International) Ltd Vifor Pharma Ltd. Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner | 2021-10-13 19:05:19 | 0 5,194,085 | 5,194,085 | Form 4 |
| TECHNE CORP 10% Owner | 2019-04-15 17:00:29 | 3,987,654 0 | 3,987,654 | Form 13G |
| ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP I LLC ISALY SAMUEL D 10% Owner | 2012-02-15 19:31:22 | 0 908,509 | 908,509 | Form 4 |
| Bekker Petrus Chief Medical Officer | 2017-07-13 19:46:45 | 721,519 0 | 721,519 | Form 4 |
| Fairey William Chief Operating Officer | 2018-01-05 19:45:16 | 575,000 0 | 575,000 | Form 4 |
| Charo Israel SVP, Research | 2014-09-22 16:44:49 | 175,000 0 | 175,000 | Form 4 |
| SINGH RAJINDER SVP, Research | 2019-04-17 18:46:12 | 157,614 0 | 157,614 | Form 4 |
| LUCAS ROGER C Director | 2019-03-08 19:20:43 | 102,267 0 | 102,267 | Form 4 |
| Kwan Pui San Principal Acctg Officer | 2021-03-01 20:54:05 | 84,353 0 | 84,353 | Form 4 |
| MCKINNELL HENRY A Director | 2022-05-24 19:34:12 | 72,749 0 | 72,749 | Form 4 |
| Jaen Juan C. SVP, Drug Discovery & CSO | 2013-07-26 13:48:45 | 70,000 0 | 70,000 | Form 4 |
| YAU YI CHING SVP, Finance & Acctg Officer | 2022-06-08 18:33:46 | 65,000 0 | 65,000 | Form 4 |
| KLEIN IRA Director | 2015-05-26 17:41:02 | 28,011 0 | 28,011 | Form 4 |
| PENHOET EDWARD Director | 2013-05-24 20:04:33 | 12,500 0 | 12,500 | Form 4 |
| Gupta Rishi Director | 2012-06-26 13:03:53 | 12,500 0 | 12,500 | Form 4 |
| Jain Rita EVP, Chief Medical Officer | 2022-10-24 19:13:58 | 0 0 | 0 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INC LAMPERT MARK N BVF INVESTMENTS LLC See Explanation of Responses | 2020-02-14 15:09:41 | 0 0 | 0 | Form 13G |
| Herron Jennifer Lyn Director | 2022-10-24 19:10:07 | 0 0 | 0 | Form 4 |
| Edwards Thomas A. Director | 2022-10-24 19:10:02 | 0 0 | 0 | Form 4 |
| Parker Geoffrey M. Director | 2022-10-24 19:08:17 | 0 0 | 0 | Form 4 |
| KANAYA SUSAN M See Remarks | 2022-10-24 19:06:25 | 0 0 | 0 | Form 4 |
| Tyree James L Director | 2022-10-24 19:02:45 | 0 0 | 0 | Form 4 |
| FECZKO JOSEPH M Director | 2022-10-24 19:01:31 | 0 0 | 0 | Form 4 |
| Schall Thomas J. President and CEO | 2022-10-24 19:01:29 | 0 0 | 0 | Form 4 |
| Cappel Markus J. Chief Bus. Officer & Treasurer | 2022-10-24 18:58:24 | 0 0 | 0 | Form 4 |
| Butt Tausif EVP, Chief Operating Officer | 2022-10-24 18:57:30 | 0 0 | 0 | Form 4 |
| Wheadon David E. Director | 2022-10-24 18:58:04 | 0 0 | 0 | Form 4 |
| Duliege Anne-Marie EVP, Chief of Strategic Dev. | 2014-11-20 19:54:10 | 0 0 | 0 | Form 4 |
| GLAXOSMITHKLINE PLC Former 10% holder | 2018-10-18 17:03:29 | 0 0 | 0 | Form 4 |